| |
|
|
|
|
|
|
|||
|
1 Nutrition and Metabolism Service, National Cancer Institute, N.I.H., P. H. S.,
D. H. E. & W., Bethesda, Maryland.
Vitamin B12-binding proteins in the serum of normal subjects and of patients with chronic myelocytic leukemia have been compared. The in-vivo-bound B12 was utilized to identify the binding protein. Column protein
chromatography and block and paper electrophoresis were employed individually and in combination to characterize the B12-binding protein. B12 was found to be bound primarily to an alpha-l globulin in both normal
individuals and in patients with chronic myelocytic leukemia. No qualitative
difference was found in these proteins. The increased amounts of B12-binding protein in the serum of patients
with chronic myelocytic leukemia would seem to be attributable to abnormal
metabolism of the same protein that binds B12 in normal serum.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1958 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||